-
1
-
-
0027193264
-
Guidelines for the adoption of new technologies: A prescription for uncontrolled growth in expenditures and how to avoid the problem
-
Gafni A, Birch S. Guidelines for the adoption of new technologies: a prescription for uncontrolled growth in expenditures and how to avoid the problem. Can Med Assoc J 1993; 148: 913-917.
-
(1993)
Can. Med. Assoc. J.
, vol.148
, pp. 913-917
-
-
Gafni, A.1
Birch, S.2
-
2
-
-
0037137077
-
Cost effectiveness analysis in health care: Contraindications
-
Donaldson C, Currie G, Mitten C. Cost effectiveness analysis in health care: contraindications. Br Med J 2002; 325: 891-894.
-
(2002)
Br. Med. J.
, vol.325
, pp. 891-894
-
-
Donaldson, C.1
Currie, G.2
Mitten, C.3
-
3
-
-
0036146631
-
Decision validity should determine whether a generic or condition-specific HRQOL measure is used in health care decisions
-
and 21-22
-
Dowie J. Decision validity should determine whether a generic or condition-specific HRQOL measure is used in health care decisions. Health Econ 2002; 11: 1-8 and 21-22.
-
(2002)
Health Econ.
, vol.11
, pp. 1-8
-
-
Dowie, J.1
-
4
-
-
84952331154
-
Guidance on the use of vinorelbine for the treatment of advanced breast cancer
-
National Institute for Clinical Excellence
-
National Institute for Clinical Excellence. Guidance on the use of vinorelbine for the treatment of advanced breast cancer. NICE Technology Appraisal Guidance 2002; 54.
-
(2002)
NICE Technology Appraisal Guidance
, vol.54
-
-
-
5
-
-
0024989695
-
The CE plane: A graphic representation of cost-effectiveness
-
Black WC. The CE plane: a graphic representation of cost-effectiveness. Med Decis Making 1990; 10: 212-240.
-
(1990)
Med. Decis. Making
, vol.10
, pp. 212-240
-
-
Black, W.C.1
-
6
-
-
0032408402
-
Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane
-
Briggs A, Fenn P. Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane. Health Econ 1998; 7: 723-740.
-
(1998)
Health Econ.
, vol.7
, pp. 723-740
-
-
Briggs, A.1
Fenn, P.2
-
7
-
-
0028509556
-
Costs, effects and C/E-ratios alongside a clinical trial
-
van Hout BA, Al MJ, Gordon GS, Rutten FFH. Costs, effects and C/E-ratios alongside a clinical trial. Health Econ 1994; 3: 309-319.
-
(1994)
Health Econ.
, vol.3
, pp. 309-319
-
-
van Hout, B.A.1
Al, M.J.2
Gordon, G.S.3
Rutten, F.F.H.4
-
8
-
-
0034010546
-
Inference for the cost-effectiveness acceptability curve and cost-effectiveness ratio
-
O'Hagan A, Stevens JW, Montmartin J. Inference for the cost-effectiveness acceptability curve and cost-effectiveness ratio. Pharmacoeconomics 2000; 17: 339-349.
-
(2000)
Pharmacoeconomics
, vol.17
, pp. 339-349
-
-
O'Hagan, A.1
Stevens, J.W.2
Montmartin, J.3
-
9
-
-
0036246479
-
Thinking outside the box: Recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies
-
Briggs AH, O'Brien BJ, Blackhouse G. Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies. Annu Rev Public Health 2002; 23: 377-401.
-
(2002)
Annu. Rev. Public Health
, vol.23
, pp. 377-401
-
-
Briggs, A.H.1
O'Brien, B.J.2
Blackhouse, G.3
-
10
-
-
0031900689
-
A new framework for the analysis of uncertainty in cost-effectiveness analysis
-
Stinnett AA, Mullahy J. A new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making 1998; 18 supp: S68 -S80.
-
(1998)
Med. Decis. Making
, vol.18
, Issue.SUPPL.
-
-
Stinnett, A.A.1
Mullahy, J.2
-
11
-
-
0036076496
-
Probabilistic analysis of cost-effectiveness models: Choosing between treatment strategies for gastroesophageal reflex disease
-
Briggs AH, Goeree R, Blackhouse G, O'Brien BJ. Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflex disease. Med Decis Making 2002; 22: 290-308.
-
(2002)
Med. Decis. Making
, vol.22
, pp. 290-308
-
-
Briggs, A.H.1
Goeree, R.2
Blackhouse, G.3
O'Brien, B.J.4
-
12
-
-
0034888930
-
Analysing health outcomes
-
Dowie J. Analysing health outcomes. J Med Ethics 2001; 17: 245-250.
-
(2001)
J. Med. Ethics
, vol.17
, pp. 245-250
-
-
Dowie, J.1
-
13
-
-
0036197997
-
Is there a kink in consumers' threshold value for cost-effectiveness in health care?
-
O'Brien BJ, Gertsen K, Willan AR, Faulkner LA. Is there a kink in consumers' threshold value for cost-effectiveness in health care? Health Econ 2002; 11: 175-180.
-
(2002)
Health Econ.
, vol.11
, pp. 175-180
-
-
O'Brien, B.J.1
Gertsen, K.2
Willan, A.R.3
Faulkner, L.A.4
-
14
-
-
0032011179
-
Assessing the value of a new pharmaceutical: A feasibility study of Contingent Valuation in managed care
-
O'Brien B, Goeree R, Gafni A, Torrance G, Pauly M, et al. Assessing the value of a new pharmaceutical: a feasibility study of Contingent Valuation in managed care. Med Care 1998; 36: 370-384.
-
(1998)
Med. Care
, vol.36
, pp. 370-384
-
-
O'Brien, B.1
Goeree, R.2
Gafni, A.3
Torrance, G.4
Pauly, M.5
-
15
-
-
0036314541
-
Unintended consequences of applying economic evaluation
-
Oliver A. Unintended consequences of applying economic evaluation. J Health Serv Res Policy 2002; 7: 129-130.
-
(2002)
J. Health Serv. Res. Policy
, vol.7
, pp. 129-130
-
-
Oliver, A.1
|